Structural Basis for Inhibition Promiscuity of Dual Specific Thrombin and Factor Xa Blood Coagulation Inhibitors
Herbert Nar(Boehringer Ingelheim (Germany)), Norbert Hauel(Boehringer Ingelheim (Germany)), Uwe J. Ries(Boehringer Ingelheim (Germany)), Angela Schmid(Boehringer Ingelheim (Germany)), Jean–Marie Stassen(Boehringer Ingelheim (Germany)), Iris K Kauffmann(Boehringer Ingelheim (Germany)), Wolfgang Wienen(Pharmazeutische Fabrik Dr. Reckeweg (Germany)), Henning Priepke(Boehringer Ingelheim (Germany))
Cited by 83
Related Papers
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
|European Journal of Pharmacology|1994|374